Search - tctmd.com

Displaying 261 - 276 of 276

Sort: Relevancy | Date

News Conference News ESC 2016

Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say

Michael O'Riordan

August 27, 2016

News Daily News

Beta-Blockers Not Beneficial After PCI for Stable Angina

Michael O'Riordan

August 17, 2016

News Daily News

Underuse of Medical Therapy Linked With Increased Adverse Events in Very Elderly

Michael O'Riordan

July 21, 2016

News Daily News

他汀类药物可降低家族性高胆固醇患者的冠心病和死亡的额外风险，但不能完全消除

July 12, 2016

News Daily News

Las Estatinas Minimizan pero No Eliminan el Exceso de Riesgo de Enfermedad Coronaria y Muerte en la Hipercolesterolemia Familiar

July 12, 2016

News Daily News

Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel

Michael O'Riordan

June 09, 2016

News Daily News

Trial Affirms Aspirin Is Safe to Continue Before Coronary Artery Surgery

February 25, 2016

News Daily News

Aspirin Hypersensitivity Can be Managed in PCI Patients Without Switching Drugs

January 20, 2016

News Daily News

Registro del CORONOR: Warfarin a Largo Plazo + Agente Antiplaquetario Aumenta las Hemorragias en Pacientes con EAC Estable

October 03, 2014

News Daily News

CORONOR Registry: Long-term Warfarin Plus Antiplatelet Increases Bleeding in Stable CAD Patients

October 03, 2014

News Daily News

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

December 16, 2012

News Daily News

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

November 28, 2012

News Daily News

CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events

June 01, 2012

News Daily News

Adding Omega-3 Fatty Acids to Dual Antiplatelet Therapy May Reduce Thrombotic Risk

May 26, 2011

News Daily News

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

May 10, 2011

Optimizing the Duration of DAPT following PCI

CME

Optimizing the Duration of DAPT following PCI

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.